Neo Ivy Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $539K | Buy |
+1,866
| New | +$539K | 0.36% | 114 |
|
|
2022
Q3 | – | Sell |
-318
| Closed | -$89K | – | 571 |
|
|
2022
Q2 | $89K | Buy |
318
+198
| +165% | +$55.4K | 0.24% | 159 |
|
|
2022
Q1 | $32K | Buy |
+120
| New | +$32K | 0.03% | 408 |
|
|
2021
Q4 | – | Sell |
-906
| Closed | -$263K | – | 644 |
|
|
2021
Q3 | $263K | Buy |
906
+131
| +17% | +$38K | 0.3% | 123 |
|
|
2021
Q2 | $156K | Buy |
775
+713
| +1,150% | +$144K | 0.16% | 213 |
|
|
2021
Q1 | $13K | Buy |
+62
| New | +$13K | 0.01% | 419 |
|
|
2020
Q3 | – | Sell |
-906
| Closed | -$263K | – | 633 |
|
|
2020
Q2 | $263K | Buy |
+906
| New | +$263K | 0.3% | 123 |
|
|
2020
Q1 | – | Sell |
-3,064
| Closed | -$671K | – | 555 |
|
|
2019
Q4 | $671K | Sell |
3,064
-4,080
| -57% | -$893K | 0.78% | 55 |
|
|
2019
Q3 | $1.29M | Buy |
+7,144
| New | +$1.29M | 0.84% | 4 |
|
|
2019
Q2 | – | Sell |
-1,318
| Closed | -$242K | – | 418 |
|
|
2019
Q1 | $242K | Buy |
+1,318
| New | +$242K | 0.14% | 191 |
|